Skip to main content

Vertical Pharmaceuticals, Inc. Recall: One (1) lot (21511158) of the OB Complete DHA is being recalled because the label claim for "Omega-3 Fatty Acids" does not match the actual formulation.

United States

TerminatedClass II

Company
Vertical Pharmaceuticals, Inc.
Product
Vertical Pharmaceuticals OB Complete with DHA Prenatal Multi…
Recall date
April 10, 2017
Terminated
April 19, 2018
Source
FDA

Reason for recall

One (1) lot (21511158) of the OB Complete DHA is being recalled because the label claim for "Omega-3 Fatty Acids" does not match the actual formulation.

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Vertical Pharmaceuticals OB Complete with DHA Prenatal Multivitamin, 60 softgels Rx Only, Manufactured for: Vertical Pharmaceuticals, LLC Sayreville, NJ 08872 UPC 368025049603 368025049603 5,734 bottles Lot number 21511158 with expiry date 10/20/2017

Distribution

  • AL
  • AR
  • AZ
  • CA
  • CO
  • FL
  • GA
  • IL
  • LA
  • MA
  • MO
  • MS
  • NC
  • NJ
  • NY
  • OH
  • OK
  • PA
  • SC
  • TX and VA

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-2208-2017
Event ID
77059
Status
Terminated
Classification
Class II
Company
Vertical Pharmaceuticals, Inc.
Product description
Vertical Pharmaceuticals OB Complete with DHA Prenatal Multivitamin, 60 softgels Rx Only, Manufactured for: Vertical Pharmaceuticals, LLC Sayreville, NJ 08872 UPC 368025049603
Quantity
5,734 bottles
Reason
One (1) lot (21511158) of the OB Complete DHA is being recalled because the label claim for "Omega-3 Fatty Acids" does not match the actual formulation.
Recall initiation date
April 10, 2017
Report date
May 17, 2017
Classification date
Not published in this source record
Termination date
April 19, 2018
Distribution pattern
AL, AR, AZ, CA, CO, FL, GA, IL, LA, MA, MO, MS, NC, NJ, NY, OH,OK, PA, SC, TX and VA
UPC, lot, and code information
UPC 368025049603; Lot number 21511158 with expiry date 10/20/2017
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Letter
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Vertical Pharmaceuticals, Inc.

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Alabama 1
Arkansas 1
Arizona 1
California 1
Colorado 1
Florida 1
Georgia 1
Illinois 1
Louisiana 1
Massachusetts 1
Missouri 1
Mississippi 1
North Carolina 1
New Jersey 1
New York 1
Ohio 1
Oklahoma 1
Pennsylvania 1
South Carolina 1
Texas 1
Virginia 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.